BCL2 and breast cancer: The PGR (progesterone receptor), BCL2 Apoptosis Regulator and SCUBE2 (Signal Peptide, CUB Domain And EGF Like Domain Containing 2) are known to be a favorable prognostic marker on breast cancer recurrence20–22.